期刊文献+

肝移植治疗转移性肝癌临床价值及评价 被引量:2

Liver transplantation for metastatic liver cancer
原文传递
导出
摘要 肝移植是治疗部分不具备手术切除条件或者其他治疗方法无效的转移性肝癌病人的有效手段。由于不同来源的肝转移肿瘤行肝移植临床效果不同,临床上应严格把握手术适应证及治疗时机,以神经内分泌来源的肿瘤,尤其是类癌来源者肝移植效果最好,是目前转移性肝癌行肝移植手术的主要适应证,而结直肠癌肝转移行肝移植的价值还尚须进一步研究。目前,对于乳腺癌等其他肿瘤来源的转移性肝癌的报道较少。 Liver transplantation is an effective treatment for some patients with metastatic liver cancers which can' t be resected and are ineffective with other treatments. Since different tumor sources will lead to different clinical results after liver transplantation. The indication and optimal time for transplantation should be controlled strictly. Currently the source of neuroendoerine tumors, especially earcinoid, is the major indication for liver transplantation. The value of liver transplantation for liver metastases of eolorectal cancer requires further research. Reports of other sources like breast cancer are very less.
作者 朱志军
出处 《中国实用外科杂志》 CSCD 北大核心 2011年第11期1006-1008,共3页 Chinese Journal of Practical Surgery
关键词 转移性肝癌 肝移植 神经内分泌肿瘤 结直肠癌 metastatic liver cancer liver transplantation neuroendocrine tumor eolorectal cancer
  • 相关文献

参考文献3

二级参考文献43

共引文献12

同被引文献38

  • 1Georgios Tsoulfas,Manousos Georgios Pramateftakis,Ioannis Kanellos.Surgical treatment of hepatic metastases from colorectal cancer[J].World Journal of Gastrointestinal Oncology,2011,3(1):1-9. 被引量:7
  • 2何晓顺,朱晓峰,张劭,王东平,马毅,鞠卫强,巫林伟,黄洁夫.肿瘤切除联合肝移植治疗消化道原发性肿瘤伴肝转移[J].中华器官移植杂志,2007,28(6):352-354. 被引量:4
  • 3Martel C ,Ferlay J,Franceschi S,et al. Global burden of cancers at-tributable to infections in 2008 : A review and synthetic analysis[J]. Lancet Oncol,2012,13(6) :607 -615.
  • 4Ruers T,Bleichrodt RP. Treatment of liver metastases,an update onthe possibilities and results [ J ]. Eur J Cancer, 2002,38(7) :1023-1033.
  • 5Mayo SC,Pulitano C,Marques H,et al. Surgical management of pa-tients with synchronous clorectal liver metastasis : A multicenter in-ternational analysis. [ J] Am Coll Surg,2013 ,216(4) :716 -718.
  • 6Frankel TL, Angelica MI. Hepatic resection for colorectal metastases[J]. J Surg Oncol’2014’109(1) :2-7.
  • 7Muratore A,Zimmitti G,Ribero D,et al. Chemotherapy between thefirst and second stages of a two - stage hepatectomy for colorectalliver metastases:Should we routinely recommend it [ J]. Ann SurgOncol,2012,19(4) :1310-1315.
  • 8Ychou M,Hohenberger W,Thezenas S,et al. A randomized phaseIII study comparing adjuvant 5 - fluorouracil/folinic acid with FOL-FIRI in patients following complete resection of liver metastasesfrom colorectal cancer [ J ]. Ann Oncol, 2009,20 ( 12 ) : 1964 —1967.
  • 9Falcone A,Ricci S,Brunetti I,et al. Phase III trial of infusional flu-orouracil ,leucovorin,oxaliplatin, and irinotecan ( FOLFOXIRI )compared with infusional fluorouracil, leucovorin, and irinotecan(FOLFIRI) as first - line treatment for metastatic colorectal canc-er ;The Gruppo Oncologicol Nord Ovest [ J ]. Clin Oncol,2007,25(13):1670 -1676.
  • 10Portier G,Elias D,Bouche 0,et al. Multicenter randomized trial ofadjuvant fluorouracil and folinic acid compared with surgery aloneafter resection of colorectal liver metastases [ J ]. Clin Oncol,2006,24(31):4976 -4982.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部